The effects of apocynin on ciprofloxacin-induced oxidative stress-related cardiotoxicity
Open Access
- 26 December 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Ciprofloxacin (CFX), a fluoroquinolone antibiotic, is known to induce oxidative stress–mediated cardiotoxicity. This study investigates the potential protective and therapeutic effects of apocynin (APO), a selective NADPH oxidase (NOX) inhibitor and potent antioxidant, against CFX-induced myocardial injury in rats. Thirty-two male Wistar albino rats were randomly divided into four groups (n = 8). CFX (25 mg/kg, i.p.) was administered twice daily for one week, while APO (20 mg/kg, i.p.) was given once daily for four days either before or after CFX treatment. Hemodynamic parameters (heart rate, systolic, diastolic, and mean blood pressures) and electrocardiographic (ECG) indices (PR, QRS, and QT intervals) were recorded invasively. Histopathological evaluations assessed myocardial inflammation, cardiomyocyte degeneration, and aortic intima–media thickness. Biochemical analyses of cardiac and aortic tissues included measurements of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) levels. CFX administration significantly elevated cardiac MDA by ~ 45% and decreased SOD and CAT activities by ~ 30–35% (p < 0.05) compared with controls. These alterations were markedly attenuated in APO-treated rats, where antioxidant enzyme activities increased by ~ 25–40% and MDA levels were restored toward normal values (p < 0.05 vs. CFX). APO also shortened the QT interval by ~ 15% and improved systolic pressure by ~ 12% compared with the CFX group (p < 0.05). Histopathological findings confirmed reduced myocardial degeneration and inflammatory infiltration in both APO + CFX and CFX + APO groups. APO effectively ameliorated CFX-induced cardiac oxidative injury by inhibiting NOX2-mediated reactive oxygen species formation and restoring antioxidant defense mechanisms, leading to functional improvement in ECG and hemodynamic parameters. These results suggest that targeted NOX inhibition may represent a practical pharmacological approach to reduce fluoroquinolone-associated cardiotoxicity, warranting further translational investigation.Keywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (1919B012000052)
This publication has 36 references indexed in Scilit:
- Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implicationsActa Pharmaceutica Sinica B, 2024
- Cardioprotective action of apocynin in isoproterenol‐induced cardiac damage is mediated through Nrf‐2/ HO ‐1 signaling pathwayFood Science & Nutrition, 2024
- Oxidative stress and cardiovascular diseases2024
- Effects of taurine and apocynin on the zone of stasisBurns, 2022
- Modulation of Oxidative Stress in Cardiovascular Diseases2019
- Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channelsBiomedicine & Pharmacotherapy, 2017
- Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in ratsChemico-Biological Interactions, 2014
- Determination of malonaldehyde precursor in tissues by thiobarbituric acid testAnalytical Biochemistry, 1978
- Catalase1965
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959